Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03086421 · ClinicalTrials.gov registry record
Social Emotional Development in Young Children With Cancer
A clinical trial of Solid Tumor, Childhood and Brain Tumor, Pediatric, sponsored by St. Jude Children's Research Hospital.
- Active
- Registry status
- 119
- Enrollment target
- 1
- Study location
NCT03086421: Active study of Solid Tumor, Childhood and Brain Tumor, Pediatric, sponsored by St. Jude Children's Research Hospital.
NCT03086421 is a study of Solid Tumor, Childhood and Brain Tumor, Pediatric that is active but no longer recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 119 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03086421, a study of Solid Tumor, Childhood and Brain Tumor, Pediatric, is active but no longer recruiting, sponsored by St. Jude Children's Research Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 119 participants
- Enrollment target
- 1
- Study location
Study Summary
Many children with cancer are diagnosed in early childhood, and as such, will likely miss key social experiences such as participation in preschool or kindergarten, playing on playgrounds, and other normative experiences. In typically-developing children, it is known that these experiences - and the skills that are learned during them - are critical to later well-being. Very little is known about the psychological functioning of young children with cancer, as studies have predominantly focused on those who are older (at least 8 years of age). This study will explicitly assess social functioning in preschool-aged children with cancer and follow the development of their social functioning from the end of treatment into survivorship. The goals of this pilot study are to begin to assess the impact of missed early childhood social experiences, as well as the interaction with developing neurocognitive problems. PRIMARY OBJECTIVE: Explore the impact of cancer in the central nervous system on social functioning of young children (ages 4-6) after completion of therapy.
Primary Outcome
Descriptive statistics will be provided. Parents will complete the Social Competence Inventory, Quality of Play Questionnaire, and the NIH Toolbox. Patients completed measures include the subtests from the NIH Toolbox, Challenging Situations Task, and Developmental Neuropsychological Assessment (2nd edition). Analyses will be completed to assess performance on these measures at each time point and to assess change over time. Analyses will be completed by diagnostic group (brain tumor versus soli
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2017-07-11 |
| Est. Completion | 2028-06 |
What the registry record for NCT03086421 still lists
NCT03086421 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Solid Tumor, Childhood appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT03086421 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03086421 about?
NCT03086421 is a clinical study titled "Social Emotional Development in Young Children With Cancer". Many children with cancer are diagnosed in early childhood, and as such, will likely miss key social experiences such as participation in preschool or kindergarten, playing on playgrounds, and other normative experiences. In typically-developing children, it is known that these experiences - and the...
What is the current status of trial NCT03086421?
This trial is currently active not recruiting. The enrollment target is 119 participants. The study started on 2017-07-11. Estimated completion is 2028-06.
What conditions does trial NCT03086421 study?
This clinical trial studies the following conditions: Solid Tumor, Childhood, Brain Tumor, Pediatric.
What interventions are being tested in trial NCT03086421?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT03086421?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03086421 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor, Childhood
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI